Your browser doesn't support javascript.
loading
Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors.
Negreros-Osuna, Adrián A; Ramírez-Mendoza, Diego A; Casas-Murillo, Claudio; Guerra-Cepeda, Abraham; Hernández-Barajas, David; Elizondo-Riojas, Guillermo.
Afiliação
  • Negreros-Osuna AA; Department of Radiology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
  • Ramírez-Mendoza DA; Department of Radiology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
  • Casas-Murillo C; Department of Radiology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
  • Guerra-Cepeda A; Department of Oncology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
  • Hernández-Barajas D; Department of Oncology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
  • Elizondo-Riojas G; Department of Radiology, School of Medicine and University Hospital 'Dr. José Eleuterio González', Autonomous University of Nuevo Leon, Monterrey, NL 64460, México.
Oncol Lett ; 24(6): 446, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36420068

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article